SENSR Biotech
Sensor Bio (formerly Biostrap) is a Houston-based B2B health technology company providing PPG-based wearable biosensors, cloud-processed physiological data, and APIs for research institutions, health systems, and digital health enterprises.
- Company typePrivate
- Founded2016
- HeadquartersHouston, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What SENSR Biotech does
SENSR Biotech, Inc. (operating as Sensor Bio, formerly Biostrap) is a Houston-based health technology company that builds a B2B clinical-grade wearable biosensing platform. The company's core offering consists of a validated PPG-based wearable device (wristband model S2001 and shoe clip form factors), a companion mobile application, the cloud-based Pulse Engine that filters, processes, and analyzes raw waveform data, and a Remote Physiological Monitoring web dashboard. The platform captures continuous ECG, PPG, SpO2, temperature, and accelerometry signals, and exposes processed biometrics including heart rate, heart rate variability (RMSSD, SDNN, pNN50), respiratory rate, arterial and peripheral elasticity, and beat shape features via APIs to EMR/EHR systems and downstream digital health products. The company serves three primary customer segments: academic and clinical research institutions requiring IRB-ready raw data workflows, health systems deploying prevention and population health monitoring, and enterprise digital health platforms building AI-driven health products on top of the biometric data layer. Named institutional partners include Stanford, NASA, NIH, Keck Medicine of USC, Duke Health, UCLA, Children's Hospital Los Angeles, Dubai Health, Medtronic, Philips, Pfizer, Cardinal Health, Biofourmis, and Therabody.
Revenue is generated through a hybrid hardware-plus-software model: direct sale of wearable biosensor devices (with 30-day return and 365-day warranty terms) paired with an enterprise SaaS subscription for the Pulse Engine, RPM dashboard, and API access. Pricing is quote-based and not publicly disclosed. Distribution occurs via direct enterprise field sales (HubSpot-scheduled meetings) and a channel partnership with Cardinal Health for healthcare system reach. Geographic focus is North America with stated intent for global expansion across healthcare, workforce safety, and wellness verticals. In February 2026 the company rebranded from Biostrap to Sensor Bio and appointed Bruce Smith (former Hydrow CEO) as CEO to accelerate scaling.
SENSR Biotech firmographics
Firmographics- Name
- SENSR Biotech
- Legal name
- Sensr Biotech, Inc.
- Website
- https://sensorbio.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sensor Bio (formerly Biostrap) is a Houston-based B2B health technology company providing PPG-based wearable biosensors, cloud-processed physiological data, and APIs for research institutions, health systems, and digital health enterprises.
- Ownership category
- akta.pro rank
SENSR Biotech industry classification
Industry- Product category
- Clinical Biometric Platform
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.) (CRACAQAH)
Keywords
Where SENSR Biotech is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SENSR Biotech business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Hardware Device Sales: Sale of wearable biosensor devices (wristbands, shoe clips) and associated proprietary hardware. Terms indicate 30-day return policy and 365-day warranty on hardware products.
- Clinical Platform Subscription: B2B SaaS platform providing continuous physiological monitoring, raw data access, and clinical infrastructure for healthcare systems, researchers, and enterprises.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
SENSR Biotech product offering
Product offeringCore offering
SENSR Biotech (operating as Sensor Bio) provides a clinical-grade wearable biosensor platform that continuously captures PPG, ECG, SpO2, temperature, and accelerometry signals via a wrist-worn device (Sensr S2001). Captured signals are processed through the proprietary cloud-based Pulse Engine to derive research-grade biometrics including heart rate, heart rate variability, respiratory rate, and cardiovascular properties, and are delivered through a mobile app, an RPM web dashboard, and open APIs for healthcare systems, academic researchers, and enterprise digital health platforms.
Product overview
Sensor Bio is a clinical-grade wearable health intelligence platform designed for B2B applications. The platform consists of a validated wearable biosensor device (Sensr wristband model S2001) paired with a mobile application and cloud-based Pulse Engine for continuous physiological signal processing. The system captures raw PPG waveforms, accelerometer, and gyroscope data, extracting biometrics including heart rate, heart rate variability, respiratory rate, and cardiovascular properties. Processed data flows to an RPM web dashboard for researchers and a mobile app for end users, all connected via standardized APIs for integration with EMR/EHR systems and clinical workflows.
Differentiator
Problem solved
Functional benefit
Products and services
- Sensor Bio Wearable Biosensor Device A validated wearable sensor device (Sensr wristband model S2001) designed for long-term continuous physiological signal capture. Uses photoplethysmography (PPG) to measure blood volume changes, with built-in accelerometer and gyroscope for motion data and sleep analysis. Captures raw PPG and derived physiological signals that are timestamped and exportable. Targeted at research institutions, healthcare systems, and enterprise digital health platforms. Hardware carries a 30-day return policy and 365-day warranty.
- Sensor Bio Mobile Application (iOS/Android) Mobile app that receives high-fidelity biosignals from the wearable device via Bluetooth Low Energy (BLE) and displays physiological metrics. Serves as the user and clinician interface for accessing continuous physiological data within existing workflows.
- Sensor Bio Pulse Engine (Cloud Processing Platform) A cloud-based computational platform that filters, cleans, processes, and analyzes PPG waveform data to extract vital biometrics including heart rate, heart rate variability (RMSSD, SDNN, pNN50), respiratory rate, arterial elasticity, peripheral elasticity, and beat shape features. Removes motion artifacts and irregular waveform patterns, then delivers processed data back to the mobile app and RPM web dashboard.
- Remote Physiological Monitoring (RPM) Web Dashboard A research-grade web dashboard providing access to raw and processed PPG, gyroscope, and accelerometer data for researchers. Supports IRB-friendly workflows and reproducible signal quality for academic and clinical studies, and includes automated arrhythmia detection and real-time clinical alerting capabilities.
Quantifiable outcome
- Validated accuracy against ECG chest straps and laboratory protocols
- +1 more outcomes
Companies that use SENSR Biotech
Customer profileNamed customers15 records
Segments3 records
Ideal customer profiles3 records
SENSR Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature5 records
SENSR Biotech partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core.
- Stanford UniversitycoreResearch validation partner providing scientific credibility for wearable biosensor technology. Stanford has validated Sensor Bio's measurements against clinical reference standards.
- NASAcoreSpace research partner validating wearable sensing technology for physiological monitoring applications.
- GatoradecoreSports science research partner using Sensor Bio technology for performance and physiological monitoring studies.
- Keck Medicine of USCcoreClinical validation partner providing healthcare system perspective on biosensor technology validation.
- Duke HealthcoreHealthcare system research partner contributing to clinical validation of biosensor technology.
- UCLAcoreAcademic research partner providing validation studies and clinical research collaboration.
- Children's Hospital Los AngelescorePediatric healthcare research partner for clinical validation studies.
- Dubai HealthcoreInternational healthcare system partner for regional validation and deployment.
- MedtroniccoreMedical device company partnership for technology validation and integration.
- PhilipscoreMedical technology partnership for health technology integration and validation.
- PfizercorePharmaceutical research partnership for clinical monitoring and therapeutic response tracking.
- NIHcoreNational Institutes of Health research partnership for validated biosensor technology in research studies.
- Cardinal HealthcoreHealthcare distribution partnership for product distribution within healthcare systems.
- BiofourmiscoreDigital health technology partnership for remote patient monitoring and analytics integration.
- TherabodycoreWellness technology partnership for integrated physiological monitoring solutions.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
SENSR Biotech competitors and assessment
Company assessmentEmerging players
- Whoop: Whoop provides a wearable strap and subscription platform for continuous physiological monitoring focused on recovery, sleep, and strain. Comparable continuous-sensing subscription model, but consumer/athlete oriented.
- Oura: Oura makes a consumer smart ring that captures continuous physiological data including heart rate, HRV, and sleep. Comparable continuous biosignal capture, but consumer-focused and consumer-grade accuracy.
Broad incumbents
- Masimo: Masimo is a large patient monitoring and pulse oximetry company with continuous SpO2 and vital sign monitoring products used in hospitals and care-at-home settings. Overlaps with Sensor Bio's multi-signal vital sign capture.
- Garmin Health: Garmin Health provides APIs and platforms for continuous wearable data from Garmin devices used in research, wellness, and population health programs. Comparable B2B continuous-biosignal-data model, but from a much larger established wearables company.
- Preventice Solutions (Boston Scientific): Preventice, now part of Boston Scientific, offers BodyGuardian remote cardiac monitoring services with cloud-based analytics. Comparable in remote cardiac monitoring and is a larger incumbent with broader portfolio.
Direct peers
- VitalConnect: VitalConnect provides wearable biosensor patches (VitalPatch) and a remote monitoring platform for cardiac and vital sign monitoring in hospital and ambulatory settings. Comparable continuous-monitoring architecture to Sensor Bio.
- iRhythm Technologies: iRhythm provides continuous ambulatory cardiac monitoring (Zio patch) with cloud-based arrhythmia detection and clinical reporting. Comparable to Sensor Bio's continuous biosignal capture and cloud analytics for clinical use cases.
- Biofourmis: Biofourmis is a remote patient monitoring and digital therapeutics platform that combines wearable biosensors with AI-driven analytics for clinical and enterprise use cases. It is both a Sensor Bio partner and a direct competitor in RPM infrastructure for health systems.
- AliveCor: AliveCor makes KardiaMobile, an FDA-cleared personal ECG device and AI-based arrhythmia detection platform used by clinicians and consumers. Highly comparable to Sensor Bio's clinical-grade ECG/PPG capture and analysis.
- Empatica: Empatica develops medical-grade wearable biosensors and a cloud platform for continuous physiological monitoring in clinical research and patient monitoring. Directly comparable to Sensor Bio's research-grade wearable + cloud pipeline model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
SENSR Biotech social profiles
Digital presenceSENSR Biotech compliance and trust
Trust signalCompliance3 records
SENSR Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
SENSR Biotech leadership team
Management profileNumber of profiles
Profiles1 record
SENSR Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SENSR Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SENSR Biotech
What does SENSR Biotech do?
SENSR Biotech (operating as Sensor Bio) provides a clinical-grade wearable biosensor platform that continuously captures PPG, ECG, SpO2, temperature, and accelerometry signals via a wrist-worn device (Sensr S2001). Captured signals are processed through the proprietary cloud-based Pulse Engine to derive research-grade biometrics including heart rate, heart rate variability, respiratory rate, and cardiovascular properties, and are delivered through a mobile app, an RPM web dashboard, and open APIs for healthcare systems, academic researchers, and enterprise digital health platforms.
Is SENSR Biotech a public or private company?
SENSR Biotech is a private company. It is classified as unknown and is currently operating.
When was SENSR Biotech founded?
SENSR Biotech was founded in 2016. It employs 11 to 50 people.
Where is SENSR Biotech based?
SENSR Biotech is headquartered in Houston, United States, in the North America region.
How does SENSR Biotech make money?
Two revenue lines are on record. Hardware Device Sales are the primary driver. The others are clinical Platform Subscription.
Who are SENSR Biotech's main competitors?
Emerging players on record are Whoop and Oura. Broad incumbents are Masimo, Garmin Health and Preventice Solutions (Boston Scientific). Direct peers are VitalConnect, iRhythm Technologies, Biofourmis, AliveCor and Empatica.
Does SENSR Biotech have an API?
Yes. Sensor Bio provides open, enterprise-grade APIs and integrations built to support research pipelines, clinical systems, and AI development. The platform offers APIs for accessing raw PPG, gyroscope, and accelerometer data. Processed biosignal data is accessible to external applications, EMR/EHR systems, wellness platforms, and hospital networks via standardized API interfaces. Mobile connectivity is established through SDK integration and Bluetooth Low Energy (BLE) protocols. Developer documentation is at sensorbio.com.
What industry is SENSR Biotech in?
SENSR Biotech's product category is Clinical Biometric Platform. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 334510 and its SIC code is 3845.